Loss of GPR133 Promotes Enzalutamide Resistance in Prostate Cancer by Upregulating HSD3B1 and Intratumoral Androgen Synthesis

Lai Wei, Ziwei Wang, Dajun Gao, Jianchao Ge, Xiaomin Chen, Huan Xu, Bin Xu

Open source

DOI
10.1002/pros.70138
Published
2026-02-10
Container
The Prostate
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/pros.70138,
  title = {Loss of GPR133 Promotes Enzalutamide Resistance in Prostate Cancer by Upregulating HSD3B1 and Intratumoral Androgen Synthesis},
  author = {Lai Wei and Ziwei Wang and Dajun Gao and Jianchao Ge and Xiaomin Chen and Huan Xu and Bin Xu},
  year = {2026},
  journal = {The Prostate},
  doi = {10.1002/pros.70138},
  url = {https://doi.org/10.1002/pros.70138}
}

RIS

TY  - JOUR
TI  - Loss of GPR133 Promotes Enzalutamide Resistance in Prostate Cancer by Upregulating HSD3B1 and Intratumoral Androgen Synthesis
AU  - Lai Wei
AU  - Ziwei Wang
AU  - Dajun Gao
AU  - Jianchao Ge
AU  - Xiaomin Chen
AU  - Huan Xu
AU  - Bin Xu
PY  - 2026
JO  - The Prostate
DO  - 10.1002/pros.70138
UR  - https://doi.org/10.1002/pros.70138
ER  - 

APA

Wei, L., Wang, Z., Gao, D., Ge, J., Chen, X., Xu, H., & Xu, B. (2026). Loss of GPR133 Promotes Enzalutamide Resistance in Prostate Cancer by Upregulating HSD3B1 and Intratumoral Androgen Synthesis. The Prostate. https://doi.org/10.1002/pros.70138

Source records